Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial function in liver disease.

Juan Sastre1, Gaetano Serviddio, Javier Pereda

  • 1Dept.of Physiology, School of Medicine, University of Valencia, Spain. juan.sastre@uv.es

Frontiers in Bioscience : a Journal and Virtual Library
|November 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same author

Clinical outcomes and remission trajectories in obese and non-obese patients with severe asthma treated with biologics: a retrospective longitudinal cohort study from the Severe Asthma Network Italy (SANI) registry.

The Lancet regional health. Europe·2026
Same author

Validation of circulating miR-323a-3p and miR-625-3p to classify hypertrophic cardiomyopathy in Friedreich's ataxia.

Scientific reports·2026
Same author

Real-world applicability of steatotic liver disease nomenclature: multifactorial phenotypes as an unmet classification need.

Internal and emergency medicine·2026
Same author

From the lab to lifestyle: epigenetic clocks in personalized aging and health.

Biogerontology·2026
Same author

Chlamydia trachomatis proctitis mimicking an inflammatory bowel disease and hiding human immunodeficiency virus infection.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Mitochondrial NADH overproduction causes oxidative stress, damaging liver cells and leading to apoptosis in alcoholic and non-alcoholic liver diseases. This oxidative stress acts as a critical factor in liver injury progression.

Area of Science:

  • Hepatology
  • Mitochondrial Biology
  • Oxidative Stress Research

Background:

  • Oxidative stress is a key factor in liver disease pathogenesis, including alcoholic liver disease and biliary cirrhosis.
  • Mitochondrial dysfunction, particularly increased reactive oxygen species (ROS) production, contributes significantly to liver cell damage.
  • Ethanol and acetaldehyde metabolism in chronic alcoholism, and cholestasis in biliary cirrhosis, induce cellular stress pathways.

Purpose of the Study:

  • To investigate the role of mitochondrial oxidative stress in the development of alcoholic and non-alcoholic liver diseases.
  • To elucidate the mechanisms linking NADH overproduction, ROS generation, and hepatocyte apoptosis.
  • To understand how mitochondrial dysfunction contributes to liver injury in chronic alcoholism and biliary cirrhosis.

Related Experiment Videos

Main Methods:

  • Analysis of mitochondrial ROS production (O2(-), H2O2) and NADH levels in liver disease models.
  • Assessment of mitochondrial membrane permeability transition (MMPT) and apoptosis markers.
  • Evaluation of changes in mitochondrial cardiolipin and membrane potential during cholestasis.
  • Investigation of the effects of ursodeoxycholic acid on mitochondrial oxidative stress.

Main Results:

  • NADH overproduction triggers mitochondrial ROS generation, leading to oxidative stress and hepatocyte apoptosis in chronic alcoholism.
  • Acetaldehyde metabolism activates MMPT and CD95-mediated apoptosis pathways, both involving ROS.
  • In biliary cirrhosis, mitochondria exhibit increased H2O2 production, GSH depletion, and loss of membrane potential, preceding apoptosis.
  • Ursodeoxycholic acid mitigates mitochondrial oxidative stress and hepatocyte apoptosis in cholestasis models.

Conclusions:

  • Mitochondrial NADH overproduction is the primary driver of chronic mitochondrial oxidative stress in both alcoholic and non-alcoholic liver diseases.
  • Mitochondrial oxidative stress acts as a crucial 'second hit,' sensitizing hepatocytes to injury and apoptosis.
  • Targeting mitochondrial dysfunction and oxidative stress pathways holds therapeutic potential for liver diseases.